Camp4 Therapeutics revenue was $5.32M for the trailing 12 months ending Sep 30, 2026, with N/A growth year over year. Quarterly revenue for the quarter (Q3 2026) ending on Sep 30, 2026 was $1.9M, up 6.7% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, CAMP annual revenue was $3.5M, with 436.5% growth year-over-year.
CAMP past revenue growth
How has CAMP's revenue growth performed historically?
On Nov 5, 2026, Camp4 Therapeutics (NASDAQ: CAMP) reported Q3 2026 revenue of $1.90 million up 138.87% year over year. In the same quarter last year, Camp4 Therapeutics's revenue was $795.00 thousand.
What was Camp4 Therapeutics's revenue in 2025?
Camp4 Therapeutics's annual revenue for the twelve months ending Dec 31, 2025 was $3.50 million, a 436.5% increase year over year.
How much does Camp4 Therapeutics make in a day?
Based on Camp4 Therapeutics annual revenue for the past three years, CAMP makes an average of $4,109.59 per day.
What was Camp4 Therapeutics's annual revenue growth in the past year?
As of Q4 2026, Camp4 Therapeutics's revenue has grown 39.93% year over year. This is 43.3 percentage points lower than the US Biotechnology industry revenue growth rate of 83.23%. Camp4 Therapeutics's revenue in the past year totaled $5.32 million.
How much does Camp4 Therapeutics make in a year?
Camp4 Therapeutics's revenue by year for the past three years is:
Camp4 Therapeutics's revenue for the twelve months ending Dec 31, 2025 was $3.50 million, a 436.5% increase year over year.
Camp4 Therapeutics's annual revenue for Dec 31, 2024 was $652.00 thousand, a 86.29% increase from 2023.
Camp4 Therapeutics's annual revenue for 2023 was $350.00 thousand, a Infinity% increase from 2022.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.